These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 7983701

  • 1. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y, Popik W, Pitha PM.
    J Virol; 1995 Jan; 69(1):110-21. PubMed ID: 7983701
    [Abstract] [Full Text] [Related]

  • 2. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P, Kwon H, Clarke M, Lin R, Sonenberg N, Wainberg M, Hiscott J.
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 4. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ, Zhang C.
    Virology; 1995 Aug 01; 211(1):157-69. PubMed ID: 7645208
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists.
    Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA.
    J Virol; 1997 Sep 01; 71(9):6486-94. PubMed ID: 9261367
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 01; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
    Gibellini D, Caputo A, Capitani S, La Placa M, Zauli G.
    Blood; 1997 Mar 01; 89(5):1654-64. PubMed ID: 9057648
    [Abstract] [Full Text] [Related]

  • 8. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H, Tarnok J, Parks WP.
    J Virol; 1998 Aug 01; 72(8):6911-6. PubMed ID: 9658145
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
    Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC.
    Proc Natl Acad Sci U S A; 1993 Sep 01; 90(17):8000-4. PubMed ID: 8367455
    [Abstract] [Full Text] [Related]

  • 10. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
    Popik W, Pitha PM.
    Proc Natl Acad Sci U S A; 1991 Nov 01; 88(21):9573-7. PubMed ID: 1719535
    [Abstract] [Full Text] [Related]

  • 11. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
    Gómez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcamí J, López-Cabrera M.
    J Biol Chem; 2001 Sep 21; 276(38):35435-43. PubMed ID: 11457829
    [Abstract] [Full Text] [Related]

  • 12. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL, Kaddour H, Schlievert PM, Stapleton JT, Okeoma CM.
    J Virol; 2018 Nov 01; 92(21):. PubMed ID: 30111566
    [Abstract] [Full Text] [Related]

  • 13. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
    Chen H, He J, Fong S, Wilcox G, Wood C.
    J Virol; 2000 Mar 01; 74(6):2703-13. PubMed ID: 10684286
    [Abstract] [Full Text] [Related]

  • 14. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD, Morris CB, Offermann MK.
    Virology; 1999 Oct 10; 263(1):128-38. PubMed ID: 10544088
    [Abstract] [Full Text] [Related]

  • 15. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
    Lin HC, Bodkin M, Lal RB, Rabson AB.
    J Virol; 1995 Nov 10; 69(11):7216-25. PubMed ID: 7474143
    [Abstract] [Full Text] [Related]

  • 16. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L, Morris GF, Lockyer JM, Lu M, Wang Z, Morris CB.
    Virology; 1997 Aug 18; 235(1):48-64. PubMed ID: 9300036
    [Abstract] [Full Text] [Related]

  • 17. Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.
    Lacoste J, D'Addario M, Roulston A, Wainberg MA, Hiscott J.
    J Virol; 1990 Oct 18; 64(10):4726-34. PubMed ID: 2204723
    [Abstract] [Full Text] [Related]

  • 18. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice.
    Sanhadji K, Leissner P, Firouzi R, Pelloquin F, Kehrli L, Marigliano M, Calenda V, Ottmann M, Tardy JC, Mehtali M, Touraine JL.
    AIDS; 1997 Jul 18; 11(8):977-86. PubMed ID: 9223731
    [Abstract] [Full Text] [Related]

  • 19. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
    Biswas DK, Ahlers CM, Dezube BJ, Pardee AB.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11044-8. PubMed ID: 8248210
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional activation of the tat-defective human immunodeficiency virus type-1 provirus: effect of interferon.
    Popik W, Pitha PM.
    Virology; 1992 Aug 01; 189(2):435-47. PubMed ID: 1641975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.